The LensOne prosthetic capsular bag is under evaluation in the upcoming GOLDEN GATE trial, which aims to assess its performance in a multicenter prospective setting.
Background
The management of aphakia or dislocated intraocular lenses (IOLs) is a significant challenge in ophthalmology, particularly in eyes lacking capsular support. Traditional approaches include various fixation techniques.
Data Highlights
No numerical data provided in the source material.
Key Findings
The LensOne prosthetic capsular bag shows a safety and efficacy profile.
It demonstrates minimal tilt and decentration of lenses.
Performance of the LensOne device is comparable to in-the-bag phaco techniques.
The GOLDEN GATE trial is set to begin this fall as a multicenter prospective pivotal trial.
Long-term safety follow-up data has been established for the prosthetic capsular bag.
Clinical Implications
The initiation of the GOLDEN GATE trial will be critical in validating these early results in a larger population.
Conclusion
Further evaluation of the LensOne prosthetic capsular bag is pending from the upcoming pivotal trial.
